Myomo, Inc.

One Broadway, 14th Floor
Cambridge
Massachusetts
02142
United States

Tel: 617-996-9058
Fax: 617-886-0333

Show jobs for this employer

154 articles about Myomo, Inc.

  • Myomo, Inc. today announced that it will report financial results for the three and nine months ended September 30, 2021 on November 10, 2021 after the market close.

  • Myomo, Inc. today announced it has entered into agreements with certain of its holders of its existing 2020 investor warrants exercisable for 1,015,798 shares of its common stock, in the aggregate, pursuant to which such holders agreed to exercise their warrants for cash at an exercise price of $5.00 per share.

  • Myomo, Inc. today announced financial results for the three and six months ended June 30, 2021.

  • Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that management will participate in A.G.P.’s Virtual MedTech Summer Conference on Thursday, July 29, 2021.

  • Myomo, Inc. Stock Added to Russell Microcap ® Index

  • Myomo, Inc.today announced that Paul R. Gudonis, Chief Executive Officer, and David Henry, Chief Financial Officer, will present a corporate overview of the company at the Sidoti Virtual Investor Conference on Wednesday, June 23, 2021.

  • Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announced that its shareholders, at its meeting on June 9, 2021, elected Milton Morris, PhD, as Director.

  • Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, provided an update regarding its application for a Healthcare Common Procedure Coding System Level II code change and benefit category redetermination for HCPCS codes L8701 and L8702 submitted in January 2021.

  • Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announced that CEO Paul R. Gudonis and CFO David Henry will present at the Summer Solstice – Best Ideas From the Buy Side Conference on June 1, 2021 at 2:30 p.m. Eastern time.

  • Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced financial results for the three months ended March 31, 2021.

  • Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announced that it will report financial results for the three months ended March 31, 2021 on May 5, 2021 after the market close.

  • Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Thomas Jefferson University of Philadelphia has successfully completed the first phase of clinical trials

  • Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announced financial results for the three months and year ended December 31, 2020.

  • Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announced that Paul R.

  • Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the three months and year ended December 31, 2020 on March 10, 2021 after the market close.

  • Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announced Techniker Krankenkasse, Germany's largest Statutory Health Insurance company, now approves reimbursement of MyoPro on a case-by-case basis.

  • Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that management will present at the Winter Wonderland – Best Ideas from the Buy-side Conference. The conference is being held virtually on February 16 th through February 19 th .

  • Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, announces the signing of a definitive agreement with Beijing Ryzur Medical Investment Co., Ltd. to form a joint venture to manufacture and sell the Company’s current and future products in greater China, including Hong Kong, Macau and Taiwan.

  • Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announced preliminary financial and operational results for the fourth quarter and fiscal year ended December 31, 2020.

  • Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that management will be presenting at the Sidoti & Company Virtual Microcap Conference on Thursday, November 19, 2020 at 1:45 p.m. Eastern Time. The presentation will be webcast live and av